KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 149 filers reported holding KURA ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,811,599 | -18.9% | 856,535 | -5.9% | 2.20% | -34.7% |
| Q2 2023 | $9,631,154 | +120.4% | 910,317 | +154.8% | 3.36% | +133.3% |
| Q1 2023 | $4,369,620 | +31.0% | 357,287 | +32.9% | 1.44% | +10.2% |
| Q4 2022 | $3,335,150 | -65.8% | 268,747 | -62.3% | 1.31% | -51.9% |
| Q3 2022 | $9,738,000 | -42.8% | 712,853 | -23.2% | 2.72% | -62.1% |
| Q2 2022 | $17,015,000 | +14.5% | 928,256 | +0.4% | 7.17% | +201.7% |
| Q1 2022 | $14,860,000 | +89.5% | 924,147 | +65.0% | 2.38% | -16.5% |
| Q4 2021 | $7,840,000 | -21.0% | 560,000 | +5.7% | 2.85% | +13.6% |
| Q3 2021 | $9,927,000 | +12.0% | 530,000 | +24.7% | 2.51% | -21.0% |
| Q2 2021 | $8,861,000 | -14.1% | 425,000 | +16.4% | 3.17% | -9.5% |
| Q1 2021 | $10,319,000 | +21.5% | 365,000 | +40.4% | 3.50% | -22.2% |
| Q4 2020 | $8,492,000 | – | 260,000 | – | 4.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |